High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$303K
$303,355
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
RAPP
S
Rapport Therapeutics, Inc.
Yeleswaram Krishnaswamy
• Officer • Chief Development Officer
10b5-1 Sell
2026-03-25
$303,355
|
||||||
| RAPP |
Rapport Therapeutics, Inc.
|
Officer • Chief Development Officer
10b5-1 Sell
|
2026-03-25 | $303,355 | S | Form 4 |